Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Depreciation and Depletion: 2020-2025

Historic Depreciation and Depletion for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to $6.0 million.

  • Maravai Lifesciences Holdings' Depreciation and Depletion rose 18.46% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.1 million, marking a year-over-year increase of 19.77%. This contributed to the annual value of $20.9 million for FY2024, which is 62.02% up from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Depreciation and Depletion stood at $6.0 million, which was up 0.30% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Depreciation and Depletion ranged from a high of $6.0 million in Q3 2025 and a low of $1.3 million during Q1 2021.
  • For the 3-year period, Maravai Lifesciences Holdings' Depreciation and Depletion averaged around $4.7 million, with its median value being $5.0 million (2024).
  • In the last 5 years, Maravai Lifesciences Holdings' Depreciation and Depletion declined by 25.72% in 2021 and then soared by 130.10% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Depreciation and Depletion (Quarterly) stood at $1.7 million in 2021, then climbed by 14.38% to $2.0 million in 2022, then spiked by 97.09% to $3.9 million in 2023, then soared by 40.16% to $5.5 million in 2024, then rose by 18.46% to $6.0 million in 2025.
  • Its Depreciation and Depletion stands at $6.0 million for Q3 2025, versus $6.0 million for Q2 2025 and $5.7 million for Q1 2025.